Chern classes, K-theory and Landweber exactness over nonregular base schemes

The purpose of this paper is twofold. First, we use the motivic Landweber exact functor theorem to deduce that the Bott inverted infinite projective space is homotopy algebraic $K$-theory. The argument is considerably shorther than any other known proofs and serves well as an illustration of the effectiveness of Landweber exactness. Second, we dispense with the regularity assumption on the base scheme which is often implicitly required in the notion of oriented motivic ring spectra. The latter allows us to verify the motivic Landweber exact functor theorem and the universal property of the algebraic cobordism spectrum for every noetherian base scheme of finite Krull dimension.Comment: minor revision, essentially in final form, to appear in Proceedings of the conference on Motives and Algebraic Cycles: A Conference Dedicated to the Mathematical Heritage of Spencer J. Bloc

Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): development, insights, and impact

Hyperhidrosis (chronic excessive sweating) may substantially affect an individual’s emotional and social well-being. Therapies available before onabotulinumtoxinA were generally topical, with limited effectiveness, application-site skin reactions, and frequent, time-consuming treatments. Intradermal injection of onabotulinumtoxinA to treat sweat glands arose as a novel therapeutic approach. To develop this treatment, appropriate dosing needed to be established, and training on administration was required. Further, no previous scale existed to measure the effects of hyperhidrosis on patients’ lives, leading Allergan to develop and validate the 4-point Hyperhidrosis Disease Severity Scale (HDSS), which measures the disease’s impact on daily activities. The onabotulinumtoxinA clinical development program for hyperhidrosis included 2 double-blind, placebo-controlled pivotal trials, immunogenicity studies, long-term studies of safety and efficacy, and quality of life assessments. In Europe and North America, the primary efficacy measures were, respectively, axillary sweat production measured gravimetrically and HDSS improvement. Compared with placebo, onabotulinumtoxinA treatment significantly reduced axillary sweat production and axillary hyperhidrosis severity, as measured by a 2-point or greater reduction on the HDSS. The effects of onabotulinumtoxinA occurred rapidly, within 1 week after injection, and lasted ≥6 months. Treatment with onabotulinumtoxinA was associated with significant quality of life improvements based on Short Form-12 physical and mental component scores. The Hyperhidrosis Impact Questionnaire also indicated greater treatment satisfaction, reduced negative impact on aspects of daily life, and improved emotional well-being with onabotulinumtoxinA versus placebo. The clinical development program and subsequent clinical experience showed that onabotulinumtoxinA treatment for hyperhidrosis was well tolerated with no new safety signals, and led to greater disease awareness

Motivic Landweber Exactness

We prove a motivic version of Landweber's exact functor theorem from topology. The main result is that the assignment given by a Landweber-type formula using the MGL-homology of a motivic spectrum defines a homology theory on the stable motivic homotopy category and is representable by a Tate-like (or cellular) spectrum. Using the universal coefficient spectral sequence of Dugger-Isaksen we deduce formulas for operations of motivic Landweber spectra of a certain type including homotopy algebraic K-theory. Finally we construct a Chern character as a map between motivic spectra.Comment: minor revision, essentially in final form, to appear in Documenta Mat

Elimination Techniques for Algorithmic Differentiation Revisited

All known elimination techniques for (first-order) algorithmic differentiation (AD) rely on Jacobians to be given for a set of relevant elemental functions. Realistically, elemental tangents and adjoints are given instead. They can be obtained by applying software tools for AD to the parts of a given modular numerical simulation. The novel generalized face elimination rule proposed in this article facilitates the rigorous exploitation of associativity of the chain rule of differentiation at arbitrary levels of granularity ranging from elemental scalar (state of the art) to multivariate vector functions with given elemental tangents and adjoints. The implied combinatorial Generalized Face Elimination problem asks for a face elimination sequence of minimal computational cost. Simple branch and bound and greedy heuristic methods are employed as a baseline for further research into more powerful algorithms motivated by promising first test results. The latter can be reproduced with the help of an open-source reference implementation

Hyperhidrosis: a central nervous dysfunction of sweat secretion

Hyperhidrosis (HH) is a central nervous dysfunction characterized by abnormally increased sweating due to a central dysregulation of sweat secretion. HH significantly affects the quality of life of patients in their private, social and professional environments. Physiologically, sweating is a mechanism that regulates body temperature, but it may also be triggered by emotional or gustatory stimuli. There are two main types of sweat glands: eccrine and apocrine glands. The central nervous system controls sweat secretion through the release of neurotransmitters into the autonomous nervous system (ANS) that activate the sweat glands. The hypothalamus has two separate neuronal pathways, one for thermoregulation and one for emotions. HH may thus be due to either a neuronal dysfunction of ANS regulation leading to a hyperactivity of the sympathetic nervous system, or to abnormal central processing of emotions. Crucially, there is no dysfunction of the sweat glands themselves. Various pathogenic mechanisms have been proposed to be involved in pathological sweat secretion in HH, ranging from structural changes within the ANS to increased expression of aquaporin 5 and upregulation of activin A receptor type 1 in eccrine sweat glands. Although a genetic predisposition has been demonstrated, it remains unclear exactly which genes are involved. To identify new, potential therapeutic targets and to improve treatment options, a good understanding of the signaling pathways involved, the underlying mechanisms, and the genetic components is essential. In this review we discuss the various aspects of sweat physiology and function that are necessary to explain pathological sweating. Our aim is to raise awareness of the complexity of HH to promote a better understanding of the disorder

Enhancing software engineering processes towards sustainable software product design

Abstract The power consumption of ICT is still increasing. To date, it is not clear if the energy savings through ICT overbalance the energy consumption by ICT, or not. Where manifold efforts of Green IT address the environmental aspects of sustainability considering computer hardware, there is a lack of models, descriptions, or realizations in the area of computer software. In this paper, we propose a generic software development process enhancement that has the potential to integrate the consideration of sustainability aspects into arbitrary software development methodologies

Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report

Prolonged-release fampridine (PR-FAM), a potassium channel blocker, is approved for improving walking ability in patients with multiple sclerosis (MS). Beyond this, positive effects on other MS symptoms like fatigue, cognition, and tremor have been described. To our knowledge, a positive effect of PR-FAM on spinal myoclonus has not been described so far. Here, we report a 32-year-old female with myoclonus after cervical myelitis affecting both hands which markedly improved after administration of PR-FAM. Treatments used before such as carbamazepine or levetiracetam had to be withdrawn because of intolerable side effects or lack of efficacy. The positive effect of PR-FAM could be confirmed by transient suspension. PR-FAM may be considered as a treatment option in refractory spinal myoclonus after myelitis in selected cases

Inflammation biomarkers in acute ischemic stroke according to different etiologies

Background: High throughput technologies provide new opportunities to further investigate the pathophysiology of ischemic strokes. The present cross-sectional study aimed to evaluate potential associations between the etiologic subtypes of ischemic stroke and blood-based proteins. Methods: We investigated the associations between ischemic stroke subtypes and a panel of circulating inflammation biomarkers in 364 patients included in the Stroke Cohort Augsburg (SCHANA). Stroke etiologies were categorized according to the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification. Serum concentrations of 52 biomarkers were measured using the Bio-Plex Pro™ Human Cytokine Screening Panel, ICAM-1 set and VCAM-1 set, plus the Pro™ Human TH17 cytokine sCD40L set and IL31 set (all Bio-Rad, USA). Multivariable linear regression models were used to examine associations. Point estimates were calculated as the mean difference in σ-standardized cytokine levels on the log2 -scale. Results: Stromal-cell-derived-factor 1 alpha (SDF-1a) showed significantly higher serum levels in cardioembolic compared with large vessel atherosclerotic stroke (β = 0.48; 95% CI 0.22; 0.75; Padj = 0.036). Significantly lower levels of interleukin-6 (IL-6) (β = -0.53; 95% CI -0.84; -0.23; Padj = 0.036) and macrophage migration inhibitory factor (MIF) (β = -0.52; 95% CI -0.84; -0.21; Padj = 0.043) were found in the small vessel versus large vessel stroke subtype. Conclusions: Immune dysregulations observed in different stroke subtypes might help uncover pathophysiological mechanisms of the disease. Further studies are needed to validate identified biomarkers in diverse study populations before they can potentially be used in clinical practice to further improve stroke management and patient outcomes